Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.

ABSTRACT:

Importance

Financial incentives shared between physicians and patients were shown to significantly reduce low-density lipoprotein cholesterol (LDL-C) levels in a randomized clinical trial, but it is not known whether these health benefits are worth the added incentive and utilization costs required to achieve them.

Objective

To evaluate the long-term cost-effectiveness of financial incentives on LDL-C level control.

Design, setting, and participants

In this economic evaluation, a previously validated microsimulation computer model was parameterized using individual-level data from the randomized clinical trial on financial incentives, National Health and Nutrition Examination Surveys for model population inputs, and other published sources. The study was conducted fro

SUBMITTER: Pandya A 

PROVIDER: S-EPMC6324619 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature